Secondhand smoke exposure and serum cytokine levels in healthy children

Karen M Wilson1, Sarah C Wesgate, Jennifer Pier

  • 1Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. karen.wilson@childrenscolorado.org

Cytokine
|July 19, 2012
PubMed

Insights

Secondhand smoke (SHS) exposure in children is linked to lower levels of key immune signaling molecules, including IL-1β and interferon-gamma (IFN-γ). This suggests SHS may suppress immune responses in young children.

Area of Science:

  • Pediatric Immunology
  • Environmental Health
  • Toxicology

Background:

  • Secondhand smoke (SHS) exposure is a known risk factor for childhood morbidity.
  • Immune system alterations may underlie the link between SHS and illness in children.
  • Limited research exists on SHS effects on children's immune responses.

Purpose of the Study:

  • To investigate the association between SHS exposure and serum cytokine levels in healthy children.
  • To quantify differences in cytokine concentrations based on SHS exposure levels.

Main Methods:

  • Recruited 40 healthy children aged 1-6 years undergoing routine procedures.
  • Assessed SHS exposure via parent interview; excluded children with asthma.
  • Measured serum cytokines using Luminex assays and cotinine levels via ELISA; analyzed data using mixed-effects models.

Main Results:

  • 65% of children had detectable SHS exposure (16 intermediate, 10 high).
  • SHS-exposed children showed lower concentrations of IL-1β, IL-4, IL-5, and IFN-γ compared to unexposed children.
  • Significant reductions in IL-1β and IFN-γ were observed in any SHS exposure group; high exposure correlated with lower IL-4.

Conclusions:

  • SHS exposure is associated with decreased expression of certain pro-inflammatory cytokines, including IFN-γ, in children.
  • Further research is required to elucidate the acute and chronic immunological impacts of SHS on children.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation